Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, clinical-stage biopharmaceutical company Cytokinetics (NASDAQ: CYTK ) has received a distressing two-star ranking.
With that in mind, let's take a closer look at Cytokinetics and see what CAPS investors are saying about the stock right now.
Cytokinetics facts
Headquarters (founded)
South San Francisco, Calif. (1997)
Market Cap
$342.1 million
Industry
Biotechnology
Trailing-12-Month Revenue
$6.6 million
Top 5 Net Payout Yield Stocks To Invest In Right Now: Reliance Steel & Aluminum Co.(RS)
Reliance Steel & Aluminum Co. operates as a metals service center company primarily in the United States and Canada. The company provides metals processing services and distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products to mills and original equipment manufacturers. Its processing services comprise cutting, leveling, sawing, machining, or electropolishing. The company also offers a range of metal perforating and fabrication services; and steel and alloy pipes, tube and bar products, and precision manufacturing of various tools designed for the global energy service companies. Reliance Steel & Aluminum Co. serves manufacturers and end-users in the general manufacturing, non-residential construction, transportation, aerospace, energy, electronics, and semiconductor fabrication and related industries. As of December 31, 2011, it maintained approximately 220 metals service center processing and distribution facilities in the United States, Belgium, Canada, China, Malaysia, Mexico, Singapore, South Korea, the United Arab Emirates, and the United Kingdom. The company was founded in 1939 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By Monica Gerson]
Reliance Steel & Aluminum Co (NYSE: RS) is estimated to report its Q3 earnings at $1.20 per share on revenue of $2.54 billion.
PulteGroup (NYSE: PHM) is expected to report its Q3 earnings at $0.36 per share on revenue of $1.46 billion.
Top Managed Healthcare Stocks To Invest In Right Now: iShares U.S. Healthcare Providers ETF (IHF)
iShares Dow Jones U.S. Health Care Providers Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Health Care Providers Index (the Index). The Index measures the performance of the healthcare providers sector of the United States equity market. The Index includes companies that are healthcare providers, such as owners and operators of health maintenance organizations, hospitals, clinics, dentists, opticians, nursing homes, rehabilitation and retirement centers.
The Fund will concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. Since all of the securities included in the Index are issued by companies in the healthcare providers sector, the Fund will be concentrated in the healthcare providers industry. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By John Udovich]
Small cap BioScrip Inc (NASDAQ: BIOS) is a specialized health care services stock that���seeking to roll-up the heavily fragmented�home infusion care market���meaning its worth taking a closer look at the stock and its performance against healthcare ETFs like the iShares Dow Jones US Health Care ETF (NYSEARCA: IHF) or the Health Care SPDR ETF (NYSEARCA: XLV). However,�BioScrip has taken a beating and I should note that we have recently added shares to our SmallCap Network Elite Opportunity (SCN EO) portfolio�because we believe the company is on the verge of turning a profit and is potentially undervalued.
- [By John Udovich]
Beaten down small cap home care and infusion stock BioScrip Inc (NASDAQ: BIOS) was recently�called a�potential takeover target, meaning its worth taking a closer look at the stock along with healthcare ETFs like the iShares Dow Jones US Health Care ETF (NYSEARCA: IHF) or the Health Care SPDR ETF (NYSEARCA: XLV).�I should mention that during the third quarter of last year, we had BioScrip in our SmallCap Network Elite Opportunity (SCN EO) portfolio after the stock had�taken a beating but we also believed the company is on the verge of turning a profit and is potentially undervalued.
Top Managed Healthcare Stocks To Invest In Right Now: Dynegy Inc (DYN)
Dynegy Inc. (Dynegy), incorporated in 2007, is a holding company and conducts the business operations through its subsidiaries. Dynegy�� primary business is the production and sale of electric energy, capacity and ancillary services from the fleet of 16 operating power plants in six states totaling approximately 11,600 megawatts of generating capacity. The Company sells electric energy, capacity and ancillary services on a wholesale basis from its power generation facilities. Its customers include Regional Transmission Organization (RTOs) and Independent System Operators (ISOs), integrated utilities, municipalities, electric cooperatives, transmission and distribution utilities, industrial customers, power marketers, financial participants, such as banks and hedge funds, and other power generators. Dynegy operates in three segments: the Coal segment (Coal), the Gas Segment (Gas) and the Dynegy Northeast Segment (DNE). In September 2011, it acquired direct ownership of Dynegy Coal Holdco, LLC. In July 2012, the Company announced that it has filed a voluntary petition to reorganize under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York, Poughkeepsie Division. It emerged from bankruptcy, on October 1, 2012. In May 2013, the Company sold its Roseton power generation facility (Roseton) to a subsidiary of Castleton Commodities International LLC (CCI).
Coal segment
Dynegy�� Coal segment consists of four operating coal-fired power generation facilities and two operating natural gas-fired peaker facilities in Illinois with a total generating capacity of 3,132 megawatts. On November 17, 2011, it permanently retired the 176 megawatts Vermilion power generation facility. As of December 31, 2011, the facilities operated entirely within MISO. Its Coal segment is primarily a fleet of baseload coal facilities, located in Illinois. The MISO market includes all of Wisconsin and portions of Michigan, Kentucky, Indian! a, Illinois, Nebraska, Kansas, Missouri, Iowa, Minnesota, North Dakota, Montana and Manitoba, Canada. MISO is as an independent RTO.
Gas Segment
Dynegy�� Gas segment consists of seven operating natural gas-fired power generation facilities located in California (two), Nevada (one), Illinois (one), Pennsylvania (one), New York (one), and Maine (one), and one fuel-oil fired power generation facility located in California, totaling 6,771 megawatts of electric generating capacity. On November 7, 2011, it deconsolidated DH, which indirectly owns all of its assets in the Gas segment. The PJM market includes all or parts of Delaware, Illinois, Indiana, Kentucky, Maryland, Michigan, New Jersey, North Carolina, Ohio, Pennsylvania, Tennessee, Virginia, West Virginia and the District of Columbia. The Company�� Kendall and Ontelaunee facilities located in Illinois and Pennsylvania operate in PJM with an aggregate net generating capacity of 1,780 megawatts.
DNE Segment
Dynegy�� DNE segment consists of the Roseton and Danskammer facilities located in Newburgh, New York, with a total capacity of 1,693 megawatts. Its total of 1,570 megawatts of generation capacity relates to leased units at the two facilities. The Company�� Roseton and Danskammer facility sites are adjacent and share common resources, such as fuel handling, a docking terminal, personnel and certain associated systems.
Advisors' Opinion:- [By Justin Loiseau]
With a successful $900 million asset sale to Dynegy (NYSE: DYN ) in March, Ameren has three leftover gas-fired energy centers it still needs to offload.
- [By Bram de Haas]
Dynegy Inc (DYN) emerged from bankruptcy last year. The share price didn't really go anywhere. In the meantime 2013 free cash flow guidance is being revised upward to $190 million - $215 million and a deal to take over capacity from Ameren Corp (AEE) is likely to be finalized in the 4th quarter. On the basis of current cash flow, the company is fairly valued. If the Ameren facilities are added in, the cash flow of the combined facilities is greatly undervalued.
- [By Ali Berri]
Dynegy (NYSE: DYN) shares shot up 7.62 percent to $31.99 after the company announced its plans to acquire assets from Duke Energy (NYSE: DUK) and Energy Capital Partners for a total consideration of $6.25 billion.
Top Managed Healthcare Stocks To Invest In Right Now: Brooks Macdonald Group PLC (BRK)
Brooks Macdonald Group plc is an integrated wealth management group, consists of three principal companies: Brooks Macdonald Asset Management Limited; Brooks Macdonald Financial Consulting Limited, which provides a bespoke, fee based, investment management service to private high net worth individuals, charities and trusts, and also provides in-house custody, nominee and dealing services; Brooks Macdonald Funds Limited, which provides fee-based, independent advice to high net worth individuals, families and businesses, and Brooks Macdonald Financial Consulting Limited, which acts as fund manager to its regulated open ended investment Companies, under the name Brooks Macdonald Funds, as well as providing specialist funds in the property and structured return sectors. It also manages property assets on behalf of the funds and other clients. Its segments include investment management, financial planning, and fund and property management. On July 1, 2012, it acquired JPAM Limited. Advisors' Opinion:- [By David Sterman]
Insurance companies are some of the best deals on the market right now, as many of them still trade below tangible book value. And considering that book value will rise more quickly as interest rates (and interest income) move higher in coming years, Buffett's Berkshire Hathaway (NYSE: BRK) could afford to pay up to 1.25 times book value and still garner excellent long-term returns. Here's a quick list of insurers that fit the bill:
- [By Bob Bogda]
The track record of the annual list is equally as impressive. Since the inaugural edition in 2003, "top stocks" have beaten the market 7 out of 10 years (the jury is still out on the current year). That beats the performance of Warren Buffett's Berkshire Hathaway (NYSE: BRK) by one year during the same span.
No comments:
Post a Comment